| Patents for C12P 21 - Preparation of peptides or proteins (112,499) |
|---|
| 04/18/2001 | EP1092037A1 Cell culture process for producing glycoproteins |
| 04/18/2001 | EP1092036A1 Method for catalysing complex reactions of large molecules using enzymes which are bonded to a polymer support |
| 04/18/2001 | EP1092032A2 Human oxidoreductase proteins |
| 04/18/2001 | EP1092029A1 A novel human thrombopoietin mutein |
| 04/18/2001 | EP1092025A1 Human emr1-like g protein coupled receptor |
| 04/18/2001 | EP1092024A2 14273 receptor, a g-protein coupled receptor |
| 04/18/2001 | EP1092023A2 Molecules associated with apoptosis |
| 04/18/2001 | EP1092021A1 Npy-y7 receptor gene |
| 04/18/2001 | EP1092017A1 Novel gaba-b receptor |
| 04/18/2001 | EP0852011A4 ANTIBODIES SPECIFIC FOR NATIVE PrP?Sc |
| 04/18/2001 | EP0766566B1 A conjugate between a modified superantigen and a target-seeking compound and the use of the conjugate |
| 04/18/2001 | EP0688431B1 Method for screening catalytic non-enzyme polypeptides and proteins |
| 04/18/2001 | EP0643835B1 Htlv-i/htlv-ii assay and method |
| 04/18/2001 | CN1292033A Baculovirus expression system and method for high through put expression of genetic material |
| 04/18/2001 | CN1292029A Compounds for therapy and diagnosis for lung cancer and method for their use |
| 04/18/2001 | CN1291992A Isolated, polypeptides which bind to HLA-A29 molecules, nucleic acid, molecules encoding there, and uses thereof |
| 04/18/2001 | CN1291991A Novel peptide having biological activity |
| 04/18/2001 | CN1291656A Nucleole antigenic monoantibody for esophagus cancer cell, reagent for diagnosing esophagus cancer, and its preparation |
| 04/18/2001 | CN1291655A Fermentation process by expressing recombined protein in bacillus |
| 04/18/2001 | CN1291617A RIM2 protein |
| 04/18/2001 | CN1064710C Therapeutic uses of keratinocyte growth factor |
| 04/18/2001 | CA2321437A1 Dna encoding structural protein-1 of infectious salmon anaemia virus and uses thereof |
| 04/17/2001 | US6218528 MurB |
| 04/17/2001 | US6218510 Proteins associated with the activation of lymphocytes and monocytes; for treatment of immune defects |
| 04/17/2001 | US6218508 Anti-microbial proteins |
| 04/17/2001 | US6218356 Neural receptor tyrosine kinase |
| 04/17/2001 | US6218162 SH2-containing inositol-phosphatase |
| 04/17/2001 | US6218149 Altering affinity of antibody for antigen by deleting dna encoding a carbohydrate recognition site from variable domain of antibody, expressing mutagenized gene, measuring affinity of altered antibody and comparing to control |
| 04/17/2001 | US6218148 DNS encoding stem cell factor |
| 04/17/2001 | US6218146 MTS2 gene |
| 04/17/2001 | US6218122 Measuring abundances of cell components for a diagnostic profile, measuring abundances of cell components in analogous subjects for response profiles, and determining interpolated response profiles which best fit diagnostic profile |
| 04/17/2001 | US6218113 Human protein kinase C inhibitor |
| 04/17/2001 | US6217866 Antitumor agents mixture |
| 04/17/2001 | US6217861 pneumococcus; use as drug target for drug screening antibiotics |
| 04/17/2001 | CA2210506C Thermostable dna polymerase from bacillus pallidus |
| 04/17/2001 | CA2125985C Stem cell inhibiting proteins |
| 04/17/2001 | CA2087436C Peptides and analogues and mixtures thereof for detecting antibodies to htlv-i and htlv-ii viruses |
| 04/12/2001 | WO2001025492A1 Human antibodies |
| 04/12/2001 | WO2001025456A2 Method for production of proteinaceous substances |
| 04/12/2001 | WO2001025446A1 Dna encoding prost 07 polypeptide |
| 04/12/2001 | WO2001025445A1 Fibrinolytically active polypeptide |
| 04/12/2001 | WO2001025437A2 Growth factor polypeptides and nucleic acids encoding same |
| 04/12/2001 | WO2001025436A2 Endozepine-like polypeptides and polynucleotides encoding same |
| 04/12/2001 | WO2001025434A1 G protein-coupled receptor up-regulated in prostate cancer and uses thereof |
| 04/12/2001 | WO2001025433A2 Novel polypeptides, their nucleic acids, and methods for their use in angiogenesis and vascularization |
| 04/12/2001 | WO2001025430A2 Novel human membrane proteins |
| 04/12/2001 | WO2001025426A1 Gene encoding protein capable of regenerating luciferin, novel recombinant dna and process for producing protein capable of regenerating luciferin |
| 04/12/2001 | WO2001025423A1 Splice variant of head trauma induced cytoplasmatic calcium binding protein |
| 04/12/2001 | WO2001025401A2 A mycobacterium tuberculosis coding sequence for expression of heterologous proteins |
| 04/12/2001 | WO2001025278A1 C-peptide for the improved production of insulin and insulin analogues |
| 04/12/2001 | WO2001025269A2 Human g-protein coupled receptor |
| 04/12/2001 | WO2001025258A1 Human inwardly rectifying potassium channel subunit |
| 04/12/2001 | WO2001025250A1 Differentially expressed genes associated with her-2/neu overexpression |
| 04/12/2001 | WO2001024819A1 YsxC |
| 04/12/2001 | WO2001024815A1 Plasminogen-like polynucleotides, polypeptides, and antibodies |
| 04/12/2001 | WO2001024681A2 Alterations in the long qt syndrome genes kvlqt1 and scn5a and methods for detecting same |
| 04/12/2001 | WO2000064938A3 Peptide homodimers or peptide heterodimers derived from interleukin 12 |
| 04/12/2001 | WO2000039289A3 Endo-beta-1,4-xylanase inhibitor aus weizenmehl und seine wirkung auf verschiedene xylanasen |
| 04/12/2001 | WO2000026667A9 Variable heavy chain and variable light chain regions of antibodies to human platelet glycoprotein ib alpha |
| 04/12/2001 | WO2000006199A8 Kvlqt1 - a long qt syndrome gene |
| 04/12/2001 | WO1997004099A3 Papillomaviruses, agents for detecting them and for treating diseases caused by such viruses |
| 04/12/2001 | US20010000241 A polynucleotide of either: (a) a polynucleotide encoding the SEQ ID NO:2; (b) a polynucleotide encoding a mature polypeptide encoded by the DNA contained in an ATCC deposit; a hybridizing polynucleotides; polypeptide receptor ligands |
| 04/12/2001 | CA2391805A1 Differentially expressed genes associated with her-2/neu overexpression |
| 04/12/2001 | CA2386854A1 Methods of using a mycobacterium tuberculosis coding sequence to facilitate stable and high yield expression of heterologous proteins |
| 04/12/2001 | CA2386383A1 Growth factor polypeptides and nucleic acids encoding same |
| 04/12/2001 | CA2386252A1 Splice variant of head trauma induced cytoplasmatic calcium binding protein |
| 04/12/2001 | CA2386236A1 Human inwardly rectifying potassium channel subunit |
| 04/12/2001 | CA2386199A1 Endozepine-like polypeptides and polynucleotides encoding same |
| 04/12/2001 | CA2386189A1 Novel human membrane proteins |
| 04/12/2001 | CA2386185A1 Fibrinolytically active polypeptide |
| 04/12/2001 | CA2385709A1 Human antibodies |
| 04/12/2001 | CA2385703A1 Plasminogen-like polynucleotides, polypeptides, and antibodies |
| 04/12/2001 | CA2385127A1 Novel hepatoma-derived growth factor-like proteins, polynulceotides encoding them and methods of use |
| 04/12/2001 | CA2385032A1 G protein-coupled receptor up-regulated in prostate cancer and uses thereof |
| 04/12/2001 | CA2382859A1 Novel polypeptides, their nucleic acids, and methods for their use in angiogenesis and vascularization |
| 04/12/2001 | CA2380807A1 Alterations in the long qt syndrome genes kvlqt1 and scn5a and methods for detecting same |
| 04/12/2001 | CA2379462A1 Human g-protein coupled receptor |
| 04/11/2001 | EP1091000A1 An attenuated vaccination and gene-transfer virus, a method to make the virus and a pharmaceutical composition comprising the virus |
| 04/11/2001 | EP1090995A2 Mycoplasma hyopneumoniae antigen MHP3, gene encoding it and uses thereof |
| 04/11/2001 | EP1090990A1 Human g-protein-coupled receptor |
| 04/11/2001 | EP1090989A1 Human g-protein-coupled receptor |
| 04/11/2001 | EP1090986A1 Protein rim 2 |
| 04/11/2001 | EP1090927A1 Polypeptide (scFv) for the detection and removal of CA19-9 antigen positive cells |
| 04/11/2001 | EP1090926A1 Human G-protein coupled receptor |
| 04/11/2001 | EP1090925A1 Human G-protein coupled receptor |
| 04/11/2001 | EP1090643A1 Remedies for hypercalcemic crisis |
| 04/11/2001 | EP1090294A1 Methods for determining presence of cancer in a sample by determining expression of an ssx gene, peptides derived from said ssx gene and ny-eso-1 gene, and uses thereof |
| 04/11/2001 | EP1090132A1 Methods for production of recombinant polypeptides |
| 04/11/2001 | EP1090120A2 Propionibacterium vector |
| 04/11/2001 | EP1090119A2 Novel olfactory receptors and their uses |
| 04/11/2001 | EP1090118A2 Human signal peptide-containing proteins |
| 04/11/2001 | EP1090112A1 Human arf-related proteins |
| 04/11/2001 | EP1090107A1 Human monoclonal antibodies against the tumor antigen uk114 and lymphocyte cells and hybridomas for their production |
| 04/11/2001 | EP1090038A2 Bispecific antibodies for retargeting anticancer cytotoxic lymphocytes and hybriomas and monoclonal antibodies therefore |
| 04/11/2001 | EP0800585B1 Hydroxyproline-rich proteins and pharmaceutical and cosmetic formulations containing them |
| 04/11/2001 | EP0733108B1 Mutants of bone morphogenetic proteins |
| 04/11/2001 | EP0710285B1 Analogues of an anti-thrombin polypeptide and process for their preparation |
| 04/11/2001 | EP0517829B1 Improved chimeric toxins |
| 04/11/2001 | CN1291231A Human telomerase catalytic subunit |
| 04/11/2001 | CN1291229A Recombinant active human zona pellucida protein 3 (h2P3) |